Bárbara Victoria Fernández García (Spain)
INSTITUTO DE INVESTIGACIONES BIOMEDICAS ALBERTO SOLS CSIC-UAM BiochemistryAuthor Of 1 Presentation
O066 - Macrophages, Smooth Muscle Cells and Nod1 inhibition in advanced stages of Atherosclerosis: a clue to plaque stabilization and atherothrombosis attenuation (ID 11)
Abstract
Background and Aims
Macrophages and Smooth Muscle Cells (SMCs) are well known to have a preeminent role in plaque necrosis and rupture. These events, added to inflammation and thin layers of collagen unchain atherothrombosis, the main cause of Acute Coronary Syndromes (ACs). Pattern recognition receptor Nucleotide-Binding Oligomerization Domain-1 (NOD1) has previously been linked to inflammation and cardiovascular diseases. The aim of this work was to unveil the function of NOD1 in the plaque stabilization phenomena in the late stages of the disease.
Methods
Athero-prone Apoe-/-Nod1-/- against Apoe-/-mice were treated with high fat diet for 16 weeks in order to characterized the advanced lesions in the aortic sinus. Proliferation, apoptosis and foam cell formation were assessed in the atheroma lesions and in primary cell cultures of macrophages and vascular SMCs. In addition, human coronary arteries were employed. Cell procedures, flow cytometry, immunofluorescences, histochemistry techniques, qRT-PCR, western blot and kinetic colorimetric assays were performed.
Results
ORO stained aorta showed a reduction in the atheroma of the double-knockout mice. NOD1 staining in human atherosclerotic coronary arteries was enhanced near lipid deposition areas and NOD1 expression was higher in Macrophages (MAC3 marker) and SMCs (Smooth Muscle α-actin marker) of these plaques. We also demonstrated that NOD1 deletion or inhibition reduced myeloid cells infiltration, macrophage and SMCs apoptosis, fibrous caps and collagen content. Interestingly, Nod1-/-SMCs presented higher proliferation rates.
Conclusions
To conclude, here we determine that both macrophages and SMCs are subjected to NOD1 regulation under advanced atherogenesis condition, triggering plaque vulnerability and thus promoting atherothrombosis and ACS.
Presenter of 1 Presentation
O066 - Macrophages, Smooth Muscle Cells and Nod1 inhibition in advanced stages of Atherosclerosis: a clue to plaque stabilization and atherothrombosis attenuation (ID 11)
Abstract
Background and Aims
Macrophages and Smooth Muscle Cells (SMCs) are well known to have a preeminent role in plaque necrosis and rupture. These events, added to inflammation and thin layers of collagen unchain atherothrombosis, the main cause of Acute Coronary Syndromes (ACs). Pattern recognition receptor Nucleotide-Binding Oligomerization Domain-1 (NOD1) has previously been linked to inflammation and cardiovascular diseases. The aim of this work was to unveil the function of NOD1 in the plaque stabilization phenomena in the late stages of the disease.
Methods
Athero-prone Apoe-/-Nod1-/- against Apoe-/-mice were treated with high fat diet for 16 weeks in order to characterized the advanced lesions in the aortic sinus. Proliferation, apoptosis and foam cell formation were assessed in the atheroma lesions and in primary cell cultures of macrophages and vascular SMCs. In addition, human coronary arteries were employed. Cell procedures, flow cytometry, immunofluorescences, histochemistry techniques, qRT-PCR, western blot and kinetic colorimetric assays were performed.
Results
ORO stained aorta showed a reduction in the atheroma of the double-knockout mice. NOD1 staining in human atherosclerotic coronary arteries was enhanced near lipid deposition areas and NOD1 expression was higher in Macrophages (MAC3 marker) and SMCs (Smooth Muscle α-actin marker) of these plaques. We also demonstrated that NOD1 deletion or inhibition reduced myeloid cells infiltration, macrophage and SMCs apoptosis, fibrous caps and collagen content. Interestingly, Nod1-/-SMCs presented higher proliferation rates.
Conclusions
To conclude, here we determine that both macrophages and SMCs are subjected to NOD1 regulation under advanced atherogenesis condition, triggering plaque vulnerability and thus promoting atherothrombosis and ACS.